Skip Navigation

Safety Study of Dasatinib With Bortezomib (Velcade) and Dexamethasone for Multiple Myeloma

Safety Study of Dasatinib With Bortezomib (Velcade) and Dexamethasone for Multiple Myeloma

Sponsor(s)

Bristol Myers Squibb

Principal Investigator(s)Jonathan L Kaufman, MD
Dates9/30/2008 - 9/30/2012